NEU 0.85% $15.14 neuren pharmaceuticals limited

ANAVEX MEETS ENDPOINTS PHASE2 RETT, page-77

  1. 923 Posts.
    lightbulb Created with Sketch. 352
    Just to clarify WAG … coz the new appointment was/is involved with Anavex …. You think that they might stymy trofinetide’s approval?
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.